Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine

Journal of Virology

Volumn 74, Issue 20, 2000, Pages 9610-9616

  Ohashi, T ^a   Hanabuchi, S ^a   Kato, H ^a   Tateno, H ^a   Takemura, F ^a   Tsukahara, T ^a   Koya, Y ^a   Hasegawa, A ^a   Masuda, T ^a   Kannagi, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; TAX PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; FEMALE; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; VACCINATION; VIRUS CARCINOGENESIS; VIRUS INHIBITION;

ADOPTIVE TRANSFER; ANIMAL; CELL LINE; FEMALE; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNIZATION; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LYMPHOPROLIFERATIVE DISORDERS; RATS; RATS, INBRED F344; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA; VIRAL VACCINES;

EID: 0033814220     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.20.9610-9616.2000     Document Type: Article

References (50)

1. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
2. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization
3. 51Cr-labelled allogeneic target cells in vitro: Inhibition by isoantibody and by drugs
4. Measles virus DNA vaccination: Antibody isotype is determined by the method of immunization and by the nature of both the antigen and the coimmunized antigen
5. + T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination
6. DNA vaccines
7. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B
8. The pX protein of HTLV-1 is a transcriptional activator of its long terminal repeats
9. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization
10. Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun
11. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes
12. c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I
13. Gene gun-based nucleic acid immunization alone or in combination with recombinant vacinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV
14. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene gun inoculations
15. Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade
16. Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime
17. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera
18. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1
19. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-1 carrier rats
20. Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization
21. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease
22. + cytotoxic T cells directed against HTLV-I-infected cells
23. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection
24. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient
25. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells
26. Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax
27. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
28. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways
29. Transcriptional activation of the interleukin-6 gene by HTLV-1 p40tax through an NF-kappa B-like binding site
30. In vivo retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for adult T cell leukemia in a rat model
31. Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1
32. Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells
33. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis
34. Gene gun-based nucleic acid immunization: Elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA
35. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery
36. Detection and isolation of type C retrovirus particles from fresh and cultured lymphoctyes of a patient with cutaneous T-cell lymphoma
37. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus
38. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice
39. Expression of the pX gene of HTLV-I: General splicing mechanism in the HTLV family
40. Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator
41. Therapeutic effects of bovine enterovirus infection on rabbits with experimentally induced adult T cell leukaemia
42. Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I
43. A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus
44. Immunogenicity of human T celt leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system
45. Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells
46. Rat lymphoid cell lines with human T cell leukemia virus production I. Biological and serological characterization
47. Adult T-cell leukemia: Clinical and hematologic features of 16 cases
48. Heterologous protection against influenza by injection of DNA encoding a viral protein
49. HTLV-1 oncoprotein tax and cellular transcription factors
50. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein